Cargando...
A Case of Tumor Necrosis Factor-α Inhibitors-induced Pustular Psoriasis
Anti-tumor necrosis factor (TNF)-α agents promise better disease control for the treatment of ankylosing spondylitis resistant to classical disease-modifying treatments. Etanercept, a recombinant human TNF receptor fusion protein, is used to treat a variety of TNF-α-mediated diseases by inhibiting t...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2010
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2883430/ https://ncbi.nlm.nih.gov/pubmed/20548918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2010.22.2.212 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|